RecruitingNot ApplicableNCT05023772

Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases

A Clinical Trial Evaluating the Efficacy of Combining Laser Interstitial Thermal Ablation With and Without Spine Stereotactic Radiosurgery for Patients With Spine Metastases


Sponsor

Henry Ford Health System

Enrollment

60 participants

Start Date

Sep 2, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research is to combine two complementary modes of treatment, spinal interstitial laser ablation and stereotactic spine radiosurgery (SSRS) for the treatment for spinal tumors near the spinal cord with an objective to improve tumor control, improve pain control, preserve function, and improve quality of life. We will also assess how effective these combined modes of treatment are in patients with spinal metastasis with an epidural component.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying MRI guided laser ablation, a procedure called Stereotactic Laser Ablation, and others for people with neoplasm metastasis, spinal cord diseases, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREStereotactic Laser Ablation

MR Guided laser ablation therapy

RADIATIONStereotactic Radiosurgery

Precise delivery of radiation to spinal tumor

DIAGNOSTIC_TESTMRI guided laser ablation

Surgery will take place in intraoperative suite to include operating room and MRI scanner


Locations(1)

Henry Ford Hospital

Detroit, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05023772


Related Trials